{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:13:06Z","timestamp":1790737986393,"version":"4.1.0"},"reference-count":139,"publisher":"Elsevier","isbn-type":[{"value":"9780128154182","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.irn.2018.07.027","type":"book-chapter","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T18:11:35Z","timestamp":1537467095000},"page":"211-250","source":"Crossref","is-referenced-by-count":68,"title":["Molecular Imaging of the Cholinergic System in Parkinson's Disease"],"prefix":"10.1016","author":[{"given":"Nicolaas I.","family":"Bohnen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabesh","family":"Kanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn L.T.M.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt. 12","key":"10.1016\/bs.irn.2018.07.027_bb0010","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1093\/brain\/awh607","article-title":"PET in LRRK2 mutations: Comparison to sporadic Parkinson's disease and evidence for presymptomatic compensation","volume":"128","author":"Adams","year":"2005","journal-title":"Brain"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/mp.2017.183","article-title":"Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV","volume":"22","author":"Aghourian","year":"2017","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0020","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/mds.1090","article-title":"Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature","volume":"16","author":"Ahlskog","year":"2001","journal-title":"Movement Disorders"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.027_bb0025","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/mds.20897","article-title":"Changes in motor subtype and risk for incident dementia in Parkinson's disease","volume":"21","author":"Alves","year":"2006","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/cne.10599","article-title":"Chemical coding of the human gastrointestinal nervous system: Cholinergic, VIPergic, and catecholaminergic phenotypes","volume":"459","author":"Anlauf","year":"2003","journal-title":"The Journal of Comparative Neurology"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.027_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00401-012-1040-2","article-title":"Parkinson's disease is not associated with gastrointestinal myenteric ganglion neuron loss","volume":"124","author":"Annerino","year":"2012","journal-title":"Acta Neuropathologica"},{"key":"10.1016\/bs.irn.2018.07.027_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00697388","article-title":"Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease","volume":"61","author":"Arendt","year":"1983","journal-title":"Acta Neuropathol (Berl)"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.027_bb0045","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1600-0404.1995.tb00443.x","article-title":"Hypersensitivity of cortical muscarinic receptors in Parkinson's disease demonstrated by PET","volume":"91","author":"Asahina","year":"1995","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/jnnp.65.2.155","article-title":"Brain muscarinic receptors in progressive supranuclear palsy and Parkinson's disease: A positron emission tomographic study","volume":"65","author":"Asahina","year":"1998","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"16","key":"10.1016\/bs.irn.2018.07.027_bb0055","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/09638280701828930","article-title":"The circumstances of falls among people with Parkinson's disease and the use of Falls Diaries to facilitate reporting","volume":"30","author":"Ashburn","year":"2008","journal-title":"Disability and Rehabilitation"},{"issue":"Pt. 1","key":"10.1016\/bs.irn.2018.07.027_bb0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/brain\/awr321","article-title":"Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: A 3 year longitudinal study","volume":"135","author":"Baba","year":"2012","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.027_bb0065","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/ntr\/ntx091","article-title":"Use of electronic cigarettes leads to significant Beta2-nicotinic acetylcholine receptor occupancy: Evidence from a PET imaging study","volume":"20","author":"Baldassarri","year":"2018","journal-title":"Nicotine & Tobacco Research"},{"key":"10.1016\/bs.irn.2018.07.027_bb0070","doi-asserted-by":"crossref","first-page":"e1618","DOI":"10.1212\/WNL.0000000000005421","article-title":"Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease","volume":"90","author":"Barrett","year":"2018","journal-title":"Neurology"},{"issue":"4558","key":"10.1016\/bs.irn.2018.07.027_bb0075","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.027_bb0080","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","article-title":"Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders","volume":"119","author":"Beach","year":"2010","journal-title":"Acta Neuropathologica"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0085","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbr.2009.12.048","article-title":"The cholinergic system and Parkinson disease","volume":"221","author":"Bohnen","year":"2011","journal-title":"Behavioural Brain Research"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","article-title":"Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects","volume":"72","author":"Bohnen","year":"2015","journal-title":"JAMA Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.027_bb0095","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/mds.25929","article-title":"Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: An in vivo positron emission tomography study","volume":"29","author":"Bohnen","year":"2014","journal-title":"Movement Disorders"},{"issue":"18","key":"10.1016\/bs.irn.2018.07.027_bb0100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1212\/WNL.0b013e3182a9f558","article-title":"Gait speed in Parkinson disease correlates with cholinergic degeneration","volume":"81","author":"Bohnen","year":"2013","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-018-0234-4","article-title":"Recent advances in cholinergic imaging and cognitive decline-revisiting the cholinergic hypothesis of dementia","volume":"7","author":"Bohnen","year":"2018","journal-title":"Current Geriatrics Reports"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0110","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/mds.25534","article-title":"Imaging: What can it tell us about parkinsonian gait?","volume":"28","author":"Bohnen","year":"2013","journal-title":"Movement Disorders"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.027_bb0115","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/jnnp.2006.100073","article-title":"Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia","volume":"78","author":"Bohnen","year":"2007","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"12","key":"10.1016\/bs.irn.2018.07.027_bb0120","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","article-title":"Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: An in vivo positron emission tomographic study","volume":"60","author":"Bohnen","year":"2003","journal-title":"Archives of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.027_bb0125","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00702-012-0956-y","article-title":"In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease","volume":"120","author":"Bohnen","year":"2013","journal-title":"Journal of Neural Transmission (Vienna)"},{"issue":"10","key":"10.1016\/bs.irn.2018.07.027_bb0130","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11910-017-0789-z","article-title":"Molecular imaging and updated diagnostic criteria in Lewy body dementias","volume":"17","author":"Bohnen","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"20","key":"10.1016\/bs.irn.2018.07.027_bb0135","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1212\/WNL.0b013e3181c1ded6","article-title":"History of falls in Parkinson disease is associated with reduced cholinergic activity","volume":"73","author":"Bohnen","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0140","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/brain\/awq079","article-title":"Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson disease","volume":"133","author":"Bohnen","year":"2010","journal-title":"Brain"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.027_bb0145","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/jcbfm.2012.60","article-title":"Heterogeneity of cholinergic denervation in Parkinson's disease without dementia","volume":"32","author":"Bohnen","year":"2012","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0155","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12974-016-0588-5","article-title":"Inflammatory profile in LRRK2-associated prodromal and clinical PD","volume":"13","author":"Brockmann","year":"2016","journal-title":"Journal of Neuroinflammation"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.027_bb0160","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/acn3.438","article-title":"Cholinergic activity and levodopa-induced dyskinesia: A multitracer molecular imaging study","volume":"4","author":"Brumberg","year":"2017","journal-title":"Annals of Clinical Translational Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.parkreldis.2015.11.029","article-title":"Neuroimaging and clinical predictors of fatigue in Parkinson disease","volume":"23","author":"Chou","year":"2016","journal-title":"Parkinsonism & Related Disorders"},{"issue":"14","key":"10.1016\/bs.irn.2018.07.027_bb0170","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e3181f6128c","article-title":"Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease","volume":"75","author":"Chung","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0175","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.0000000000002839","article-title":"Cholinergic and perfusion brain networks in Parkinson disease dementia","volume":"87","author":"Colloby","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.neuroimage.2006.07.026","article-title":"In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia","volume":"33","author":"Colloby","year":"2006","journal-title":"NeuroImage"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0185","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/JGP.0b013e3181b972aa","article-title":"Nicotinic 123I-5IA-85380 single photon emission computed tomography as a predictor of cognitive progression in Alzheimer's disease and dementia with Lewy bodies","volume":"18","author":"Colloby","year":"2010","journal-title":"The American Journal of Geriatric Psychiatry"},{"issue":"12","key":"10.1016\/bs.irn.2018.07.027_bb0190","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1001\/archneur.64.12.1771","article-title":"Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease","volume":"64","author":"Counts","year":"2007","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0195","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/j.neurobiolaging.2013.04.027","article-title":"Functional variability in butyrylcholinesterase activity regulates intrathecal cytokine and astroglial biomarker profiles in patients with Alzheimer's disease","volume":"34","author":"Darreh-Shori","year":"2013","journal-title":"Neurobiology of Aging"},{"key":"10.1016\/bs.irn.2018.07.027_bb0200","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"II","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/bs.irn.2018.07.027_bb0205","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1001\/jama.281.15.1401","article-title":"Cholinergic markers in elderly patients with early signs of Alzheimer disease","volume":"281","author":"Davis","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0210","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.10069","article-title":"Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment","volume":"51","author":"DeKosky","year":"2002","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.027_bb0215","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nrneurol.2012.80","article-title":"Olfactory dysfunction in Parkinson disease","volume":"8","author":"Doty","year":"2012","journal-title":"Nature Reviews. Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0220","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archneur.1974.00490320001001","article-title":"Human memory and the cholinergic system. A relationship to aging?","volume":"30","author":"Drachman","year":"1974","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0225","first-page":"21","article-title":"Paying attention to smell: Cholinergic signaling in the olfactory bulb","volume":"6","author":"D'Souza","year":"2014","journal-title":"Frontiers in Synaptic Neuroscience"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.027_bb0230","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.neurobiolaging.2010.10.019","article-title":"Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance","volume":"33","author":"Ewers","year":"2012","journal-title":"Neurobiology of Aging"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.027_bb0235","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1212\/WNL.0000000000003633","article-title":"Decreased intestinal acetylcholinesterase in early Parkinson disease: An (11)C-donepezil PET study","volume":"88","author":"Fedorova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0240","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0165-0173(82)90011-X","article-title":"The organization and some projections of cholinergic neurons of the mammalian forebrain","volume":"4","author":"Fibiger","year":"1982","journal-title":"Brain Research Reviews"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0245","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.20688","article-title":"Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease","volume":"59","author":"Fujita","year":"2006","journal-title":"Annals of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0250","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.21680","article-title":"Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's disease","volume":"66","author":"Gagnon","year":"2009","journal-title":"Annals of Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.027_bb0255","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10072-016-2504-2","article-title":"Indoor and outdoor falls in persons with Parkinson's disease after 1 year follow-up study: Differences and consequences","volume":"37","author":"Gazibara","year":"2016","journal-title":"Neurological Sciences"},{"issue":"18","key":"10.1016\/bs.irn.2018.07.027_bb0260","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1212\/WNL.0b013e3181dc1a55","article-title":"Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes","volume":"74","author":"Gilman","year":"2010","journal-title":"Neurology"},{"issue":"Pt. 3","key":"10.1016\/bs.irn.2018.07.027_bb0265","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/brain\/awu369","article-title":"Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET","volume":"138","author":"Gjerloff","year":"2015","journal-title":"Brain"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0270","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2967\/jnumed.114.143859","article-title":"In vivo imaging of human acetylcholinesterase density in peripheral organs using 11C-donepezil: Dosimetry, biodistribution, and kinetic analyses","volume":"55","author":"Gjerloff","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"issue":"Pt. 6","key":"10.1016\/bs.irn.2018.07.027_bb0275","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson's disease dementia: A neural networks perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.027_bb0280","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson's disease","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathologica"},{"issue":"7","key":"10.1016\/bs.irn.2018.07.027_bb0285","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","article-title":"Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: A case-control study","volume":"7","author":"Healy","year":"2008","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0290","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/cne.903250107","article-title":"Cholinergic innervation of the human thalamus: Dual origin and differential nuclear distribution","volume":"325","author":"Heckers","year":"1992","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0295","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1474-4422(15)00389-0","article-title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): A randomised, double-blind, placebo-controlled, phase 2 trial","volume":"15","author":"Henderson","year":"2016","journal-title":"Lancet Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0300","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1212\/01.wnl.0000191154.78131.f6","article-title":"Dementia in Parkinson disease: Functional imaging of cholinergic and dopaminergic pathways","volume":"65","author":"Hilker","year":"2005","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0305","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000338774","article-title":"Cholinergic deficit and response to donepezil therapy in Parkinson's disease with dementia","volume":"68","author":"Hiraoka","year":"2012","journal-title":"European Neurology"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.027_bb0310","doi-asserted-by":"crossref","first-page":"672","DOI":"10.2967\/jnumed.113.132068","article-title":"18F-ASEM, a radiolabeled antagonist for imaging the alpha7-nicotinic acetylcholine receptor with PET","volume":"55","author":"Horti","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.027_bb0315","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.64.9.1312","article-title":"Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease","volume":"64","author":"Ikonomovic","year":"2007","journal-title":"Archives of Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0320","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0969-8051(94)90159-7","article-title":"Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AChE) in vivo","volume":"21","author":"Irie","year":"1994","journal-title":"Nuclear Medicine and Biology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0325","first-page":"649","article-title":"Brain acetylcholinesterase activity: Validation of a PET tracer in a rat model of Alzheimer's disease","volume":"37","author":"Irie","year":"1996","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2018.07.027_bb0330","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fnagi.2014.00213","article-title":"Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's disease","volume":"6","author":"Isaias","year":"2014","journal-title":"Frontiers in Aging Neuroscience"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0335","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/psyg.12045","article-title":"Effects of donepezil dose escalation in Parkinson's patients with dementia receiving long-term donepezil treatment: An exploratory study","volume":"14","author":"Ishikawa","year":"2014","journal-title":"Psychogeriatrics"},{"key":"10.1016\/bs.irn.2018.07.027_bb0340","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0140-6736(96)09124-6","article-title":"Measurement of acetylcholinesterase by positron emission tomography in the brain of healthy controls and patients with Alzheimer's disease","volume":"349","author":"Iyo","year":"1997","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/bs.irn.2018.07.027_bb0345","first-page":"S19","article-title":"Biomarkers for cognitive dysfunction in Parkinson's disease","volume":"46","author":"Kalia","year":"2017","journal-title":"Parkinsonism & Related Disorders"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0350","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","article-title":"Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease","volume":"72","author":"Kalia","year":"2015","journal-title":"JAMA Neurology"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.027_bb0355","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1172\/JCI42642","article-title":"Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease","volume":"120","author":"Karachi","year":"2010","journal-title":"The Journal of Clinical Investigation"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.027_bb0360","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jcbfm.2009.74","article-title":"Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease","volume":"29","author":"Kas","year":"2009","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"21\u221222","key":"10.1016\/bs.irn.2018.07.027_bb0365","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.lfs.2012.05.006","article-title":"Critical roles of acetylcholine and the muscarinic and nicotinic acetylcholine receptors in the regulation of immune function","volume":"91","author":"Kawashima","year":"2012","journal-title":"Life Sciences"},{"issue":"12","key":"10.1016\/bs.irn.2018.07.027_bb0370","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease","volume":"9","author":"Kehagia","year":"2010","journal-title":"Lancet Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0375","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1098-2396(199602)22:2<123::AID-SYN5>3.0.CO;2-F","article-title":"In vivo studies of acetylcholinesterase activity using a labeled substrate, N-[11C]methylpiperdinyl-4-propionate ([11C]PMP)","volume":"22","author":"Kilbourn","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/bs.irn.2018.07.027_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2018.01.021","article-title":"Compensatory dopaminergic-cholinergic interactions in conflict processing: Evidence from patients with Parkinson's disease","author":"Kim","year":"2018","journal-title":"NeuroImage"},{"key":"10.1016\/bs.irn.2018.07.027_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2017.12.012","article-title":"The cortical cholinergic system contributes to the top-down control of distraction: Evidence from patients with Parkinson's disease","author":"Kim","year":"2017","journal-title":"NeuroImage"},{"key":"10.1016\/bs.irn.2018.07.027_bb0390","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuroimage.2017.02.006","article-title":"Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson's disease patients with defined cholinergic losses","volume":"149","author":"Kim","year":"2017","journal-title":"NeuroImage"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0395","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","article-title":"Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo","volume":"74","author":"Klein","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0400","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/00004647-199910000-00012","article-title":"Kinetic modeling of N-[11C]methylpiperidin-4-yl propionate: Alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain","volume":"19","author":"Koeppe","year":"1999","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.027_bb0405","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/ana.22691","article-title":"Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease","volume":"71","author":"Kotagal","year":"2012","journal-title":"Annals of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0410","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neulet.2012.02.083","article-title":"Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders","volume":"514","author":"Kotagal","year":"2012","journal-title":"Neuroscience Letters"},{"issue":"10","key":"10.1016\/bs.irn.2018.07.027_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of alpha-Synuclein and Abeta in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer","year":"2012","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0420","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/ejn.13354","article-title":"Reducing falls in Parkinson's disease: Interactions between donepezil and the 5-HT6 receptor antagonist idalopirdine on falls in a rat model of impaired cognitive control of complex movements","volume":"45","author":"Kucinski","year":"2017","journal-title":"The European Journal of Neuroscience"},{"issue":"42","key":"10.1016\/bs.irn.2018.07.027_bb0425","doi-asserted-by":"crossref","first-page":"16522","DOI":"10.1523\/JNEUROSCI.2545-13.2013","article-title":"Modeling fall propensity in Parkinson's disease: Deficits in the attentional control of complex movements in rats with cortical-cholinergic and striatal-dopaminergic deafferentation","volume":"33","author":"Kucinski","year":"2013","journal-title":"The Journal of Neuroscience"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0430","first-page":"405","article-title":"In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM","volume":"35","author":"Kuhl","year":"1994","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2018.07.027_bb0435","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1212\/WNL.52.4.691","article-title":"In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease","volume":"52","author":"Kuhl","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0440","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410400309","article-title":"In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease","volume":"40","author":"Kuhl","year":"1996","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.027_bb0445","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archneur.64.9.1242","article-title":"The relationship of Parkinson disease with aging","volume":"64","author":"Levy","year":"2007","journal-title":"Archives of Neurology"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.07.027_bb0450","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000438824","article-title":"Impact of rivastigmine on cognitive dysfunction and falling in Parkinson's disease patients","volume":"74","author":"Li","year":"2015","journal-title":"European Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0455","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(18)30032-2","article-title":"The influence of LRRK2 mutations on the cholinergic system in manifest and prodromal stages of Parkinson's disease: A cross-sectional PET study","volume":"17","author":"Liu","year":"2018","journal-title":"Lancet Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0460","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.gaitpost.2009.09.019","article-title":"Executive dysfunction and attention contribute to gait interference in \u2018off\u2019 state Parkinson's disease","volume":"31","author":"Lord","year":"2010","journal-title":"Gait & Posture"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.027_bb0465","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s00415-015-7750-3","article-title":"Functional connectome assessed using graph theory in drug-naive Parkinson's disease","volume":"262","author":"Luo","year":"2015","journal-title":"Journal of Neurology"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0470","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3233\/JAD-2012-111748","article-title":"[11C]-MP4A PET cholinergic measurements in amnestic mild cognitive impairment, probable Alzheimer's disease, and dementia with Lewy bodies: A Bayesian method and voxel-based analysis","volume":"31","author":"Marcone","year":"2012","journal-title":"Journal of Alzheimer's Disease"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0475","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00415-008-0629-9","article-title":"Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?","volume":"255","author":"Marion","year":"2008","journal-title":"Journal of Neurology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0480","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnumed.116.176180","article-title":"123I-iodobenzovesamicol SPECT imaging of cholinergic systems in dementia with Lewy bodies","volume":"58","author":"Mazere","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0485","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0490","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0079-6123(08)62112-3","article-title":"The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease","volume":"109","author":"Mesulam","year":"1996","journal-title":"Progress in Brain Research"},{"key":"10.1016\/bs.irn.2018.07.027_bb0495","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/cne.903230209","article-title":"Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus","volume":"323","author":"Mesulam","year":"1992","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0500","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/cne.902140206","article-title":"Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey","volume":"214","author":"Mesulam","year":"1983","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0505","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0306-4522(83)90108-2","article-title":"Central cholinergic pathways in the rat: An overview based on an alternative nomenclature (CH1-CH-6)","volume":"10","author":"Mesulam","year":"1983","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/bs.irn.2018.07.027_bb0510","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","article-title":"Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease","volume":"66","author":"Meyer","year":"2009","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0515","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<263::AID-SYN4>3.0.CO;2-9","article-title":"[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses","volume":"30","author":"Mulholland","year":"1998","journal-title":"Synapse"},{"issue":"Pt. 11","key":"10.1016\/bs.irn.2018.07.027_bb0520","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1093\/brain\/awt247","article-title":"Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease","volume":"136","author":"Muller","year":"2013","journal-title":"Brain"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.027_bb0525","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11910-013-0377-9","article-title":"Cholinergic dysfunction in Parkinson's disease","volume":"13","author":"Muller","year":"2013","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0530","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1097\/00004647-200111000-00011","article-title":"Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling","volume":"21","author":"Nagatsuka","year":"2001","journal-title":"Journal of Cerebral Blood Flow and Metabolism"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0535","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/mds.25683","article-title":"Characterizing freezing of gait in Parkinson's disease: Models of an episodic phenomenon","volume":"28","author":"Nieuwboer","year":"2013","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0540","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.neuroimage.2008.01.010","article-title":"Nicotinic alpha4beta2 receptor binding in dementia with Lewy bodies using 123I-5IA-85380 SPECT demonstrates a link between occipital changes and visual hallucinations","volume":"40","author":"O'Brien","year":"2008","journal-title":"NeuroImage"},{"issue":"1\u20132","key":"10.1016\/bs.irn.2018.07.027_bb0545","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jns.2007.02.014","article-title":"Quantification of nicotinic acetylcholine receptors in Parkinson's disease with (123)I-5IA SPECT","volume":"256","author":"Oishi","year":"2007","journal-title":"Journal of the Neurological Sciences"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0550","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11910-017-0794-2","article-title":"PET molecular imaging research of levodopa-induced dyskinesias in Parkinson's disease","volume":"17","author":"Pagano","year":"2017","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/bs.irn.2018.07.027_bb0555","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1038\/npjparkd.2016.1","article-title":"Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease","volume":"2","author":"Perez-Lloret","year":"2016","journal-title":"NPJ Parkinson's Disease"},{"key":"10.1016\/bs.irn.2018.07.027_bb0560","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(77)91780-9","article-title":"Necropsy evidence of central cholinergic deficits in senile dementia","volume":"I","author":"Perry","year":"1977","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0565","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2967\/jnumed.113.124792","article-title":"In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: Biodistribution, dosimetry, and tracer kinetic analyses","volume":"55","author":"Petrou","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2018.07.027_bb0570","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/bs.irn.2015.07.005","article-title":"Nicotine and nicotinic receptor drugs: Potential for Parkinson's disease and drug-induced movement disorders","volume":"124","author":"Quik","year":"2015","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0575","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.027_bb0580","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5114\/ninp.2013.38222","article-title":"Causes and consequences of falls in Parkinson disease patients in a prospective study","volume":"47","author":"Rudzinska","year":"2013","journal-title":"Neurologia i Neurochirurgia Polska"},{"key":"10.1016\/bs.irn.2018.07.027_bb0585","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1093\/brain\/awy099","article-title":"Cognitive correlates of \u03b14\u03b22 nicotinic acetylcholine receptors in mild Alzheimer's dementia","volume":"141","author":"Sabri","year":"2018","journal-title":"Brain"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0590","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF02996300","article-title":"Evaluation of radioiodinated 5-iodo-3-(2(S)-azetidinylmethoxy)pyridine as a ligand for SPECT investigations of brain nicotinic acetylcholine receptors","volume":"16","author":"Saji","year":"2002","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1016\/bs.irn.2018.07.027_bb0595","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.expneurol.2014.04.032","article-title":"Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal function","volume":"257C","author":"Sarter","year":"2014","journal-title":"Experimental Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0600","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/ncomms13249","article-title":"Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology","volume":"7","author":"Schmitz","year":"2016","journal-title":"Nature Communications"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.027_bb0605","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/brain\/awy072","article-title":"Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease","volume":"141","author":"Schulz","year":"2018","journal-title":"Brain"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0610","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/mds.26369","article-title":"Striatal and cortical beta-amyloidopathy and cognition in Parkinson's disease","volume":"31","author":"Shah","year":"2016","journal-title":"Movement Disorders"},{"issue":"4","key":"10.1016\/bs.irn.2018.07.027_bb0615","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0620","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/gps.4338","article-title":"Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study","volume":"30","author":"Shimada","year":"2015","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0625","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02252661","article-title":"Effects of trihexyphenidyl and L-dopa on brain muscarinic cholinergic receptor binding measured by positron emission tomography","volume":"7","author":"Shinotoh","year":"1994","journal-title":"Journal of Neural Transmission. Parkinson's Disease and Dementia Section"},{"key":"10.1016\/bs.irn.2018.07.027_bb0630","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1531-8249(199907)46:1<62::AID-ANA10>3.0.CO;2-P","article-title":"Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy","volume":"46","author":"Shinotoh","year":"1999","journal-title":"Annals of Neurology"},{"key":"10.1016\/bs.irn.2018.07.027_bb0635","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/BF00406286","article-title":"Electron microscopy of cholinergic terminals and acetylcholinesterase-containing neurones in the hippocampal formation of the rat","volume":"69","author":"Shute","year":"1966","journal-title":"Zeitschrift f\u00fcr Zellforschung und Mikroskopische Anatomie"},{"issue":"2","key":"10.1016\/bs.irn.2018.07.027_bb0640","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.bmc.2013.12.011","article-title":"Synthesis and biological evaluation of both enantiomers of [(18)F]flubatine, promising radiotracers with fast kinetics for the imaging of alpha4beta2-nicotinic acetylcholine receptors","volume":"22","author":"Smits","year":"2014","journal-title":"Bioorganic & Medicinal Chemistry"},{"key":"10.1016\/bs.irn.2018.07.027_bb0645","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0969-8051(98)00045-6","article-title":"Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) for in vivo measurements of acetylcholinesterase activity","volume":"25","author":"Snyder","year":"1998","journal-title":"Nuclear Medicine and Biology"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0650","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.parkreldis.2013.08.021","article-title":"Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease","volume":"20","author":"Weathers","year":"2014","journal-title":"Parkinsonism & Related Disorders"},{"issue":"9","key":"10.1016\/bs.irn.2018.07.027_bb0655","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/mds.20555","article-title":"Antidepressant studies in Parkinson's disease: A review and meta-analysis","volume":"20","author":"Weintraub","year":"2005","journal-title":"Movement Disorders"},{"key":"10.1016\/bs.irn.2018.07.027_bb0660","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ana.410130304","article-title":"Basal forebrain neurons in the dementia of Parkinson disease","volume":"13","author":"Whitehouse","year":"1983","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1016\/bs.irn.2018.07.027_bb0665","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-Year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"1","key":"10.1016\/bs.irn.2018.07.027_bb0670","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1148\/radiol.12112723","article-title":"Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET","volume":"265","author":"Wong","year":"2012","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.027_bb0675","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0301-0082(91)90006-M","article-title":"Cholinergic systems in mammalian brain and spinal cord","volume":"37","author":"Woolf","year":"1991","journal-title":"Progress in Neurobiology"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0680","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/ana.410340312","article-title":"Neurological cholinesterases in the normal brain and in Alzheimer's disease: Relationship to plaques, tangles, and patterns of selective vulnerability","volume":"34","author":"Wright","year":"1993","journal-title":"Annals of Neurology"},{"issue":"14","key":"10.1016\/bs.irn.2018.07.027_bb0685","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/mds.23932","article-title":"The interplay of cholinergic function, attention, and falls in Parkinson's disease","volume":"26","author":"Yarnall","year":"2011","journal-title":"Movement Disorders"},{"issue":"3","key":"10.1016\/bs.irn.2018.07.027_bb0690","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1152\/jn.00338.2011","article-title":"The organization of the human cerebral cortex estimated by intrinsic functional connectivity","volume":"106","author":"Yeo","year":"2011","journal-title":"Journal of Neurophysiology"},{"issue":"5","key":"10.1016\/bs.irn.2018.07.027_bb0695","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/j.1460-9568.2005.04298.x","article-title":"Dual tasking, gait rhythmicity, and Parkinson's disease: Which aspects of gait are attention demanding?","volume":"22","author":"Yogev","year":"2005","journal-title":"The European Journal of Neuroscience"},{"issue":"6","key":"10.1016\/bs.irn.2018.07.027_bb0700","first-page":"759","article-title":"Outcomes of Alzheimer's disease therapy with acetylcholinesterase inhibitors and memantine","volume":"13","author":"Zemek","year":"2014","journal-title":"Expert Opinion on Drug Safety"}],"container-title":["International Review of Neurobiology","Imaging in Movement Disorders: Imaging Methodology and Applications in Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218300564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0074774218300564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T18:27:44Z","timestamp":1539109664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0074774218300564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128154182"],"references-count":139,"URL":"https:\/\/doi.org\/10.1016\/bs.irn.2018.07.027","relation":{},"ISSN":["0074-7742"],"issn-type":[{"value":"0074-7742","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}